NORTHERN TRUST CORP - MARINUS PHARMACEUTICALS INC ownership

MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 97 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of MARINUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$2,591,000
+36.5%
1,020,012
+9.1%
0.00%0.0%
Q1 2020$1,898,000
+64.9%
935,088
+75.5%
0.00%
Q4 2019$1,151,000
+30.6%
532,964
-6.9%
0.00%
Q3 2019$881,000
-61.3%
572,265
+4.3%
0.00%
-100.0%
Q2 2019$2,276,000
+1.2%
548,467
+1.9%
0.00%0.0%
Q1 2019$2,250,000
+96.0%
538,263
+34.6%
0.00%
Q4 2018$1,148,000
-71.4%
399,908
-0.4%
0.00%
-100.0%
Q3 2018$4,017,000
+46.8%
401,709
+3.8%
0.00%0.0%
Q2 2018$2,736,000
+1241.2%
386,864
+625.7%
0.00%
Q1 2018$204,000
-50.5%
53,309
+5.6%
0.00%
Q4 2017$412,000
+53.7%
50,472
+10.5%
0.00%
Q3 2017$268,000
+824.1%
45,678
+112.8%
0.00%
Q2 2017$29,000
-23.7%
21,4700.0%0.00%
Q1 2017$38,000
+72.7%
21,4700.0%0.00%
Q4 2016$22,000
-42.1%
21,470
+1.7%
0.00%
Q3 2016$38,000
+40.7%
21,1080.0%0.00%
Q2 2016$27,000
-76.3%
21,1080.0%0.00%
Q1 2016$114,000
-21.4%
21,108
+11.6%
0.00%
Q4 2015$145,00018,9200.00%
Other shareholders
MARINUS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 3,977,453$15,194,0008.96%
Granite Point Capital Management, L.P. 2,638,321$10,078,0000.98%
New Leaf Venture Partners, L.L.C. 342,550$1,309,0000.71%
683 Capital Management, LLC 1,200,000$4,584,0000.40%
Virtus ETF Advisers LLC 80,389$307,0000.27%
Iguana Healthcare Management, LLC 100,000$382,0000.25%
THREE BAYS CAPITAL LP 944,300$3,607,0000.25%
Granite Point Capital Management, L.P. 549,900$2,101,0000.20%
Cormorant Asset Management, LP 478,111$1,826,0000.14%
GMT CAPITAL CORP 2,533,798$9,680,0000.12%
View complete list of MARINUS PHARMACEUTICALS INC shareholders